John Kiely, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 32,000 shares at $9.23 ($295K) on 2025-08-27, disclosed to the SEC on 2025-08-28.
Open-market sale of $295k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMRX | SELL | 2024-11-26 | $286K | — | Filing → |
| ZVO | BUY | 2020-09-10 | $43K | — | Filing → |
| AMRX | BUY | 2020-05-19 | $44K | — | Filing → |